Lexapro Improves Depression Symptoms In Adolescents
Forest Laboratories's study results show Lexapro significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder.
DAYTRANA Offers ADHD Symptoms Control For 12 Months
Shire plc announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).
FDA Approves Strattera For ADHD Treatment
Eli Lilly and Company announced that FDA has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
Short Arms, Legs Linked To Risk Of Dementia
People with shorter arms and legs may be at a higher risk for developing dementia later in life compared to people with longer arms and legs.
MUHC searches for causes of autism
The international research for finding the causes of autism is considered groundbreaking and will be based on the DNA samples of patients with autism.
Post-War Suicide Rates Extremely High
Depression and post-traumatic stress disorder are very high among veterans from wars in Iraq and Afghanistan, leading to suicide rates even higher than combat deaths
58%
